Abolishing Brachyury Function through Degradation


Therapeutic Innovation Award, in partnership with Chordoma Foundation (2018-Present)

Development of a PROteolysis TArgeting Chimera (PROTAC)-based drug candidate to degrade intracellular brachyury and abrogate its oncogenic function

BACK TO OUR PORTFOLIO